Subscribe to RSS
Trends in the Management Paradigms of Intracranial Meningioma
Objective Intracranial meningiomas are the most common primary brain tumor. Treatment paradigms have evolved over time. There are limited number of population-based studies that examine this modern evolution. Here, we describe the trends of management of intracranial meningiomas using a national database.
Methods The data were obtained from the National Cancer Database for the years 2004 to 2015, the collected variables included: patients' age, gender, insurance type, income, comorbidity score, the tumor size and grade, and treatment modality (observation, surgery, radiotherapy, or combination therapy). We performed statistical analyses to detect association between unique variables and outcomes. In addition, we performed mortality analyses for various treatment modalities.
Results A total of 199,096 patients with a diagnosis of intracranial meningioma were included, the majority of patients were white females, mean age of 61 years, and half of the tumors were ≤ 3 cm. Observation was the most commonly used management modality followed by surgical resection, radiotherapy, and combination therapy. For the entire time period, there was an increased use of observation as a primary management method. Predictors of mortality included increased age, larger tumor size, higher tumor grade, treatment at a community hospital, and higher comorbidity scores.
Conclusion Population-based studies of intracranial meningiomas are uncommon; our study is one of the few reports that examine the changes in the modern management paradigms of meningioma in the United States over time. Additionally, we shed light on the factors that affected survival of patients with this condition.
Brian J. Williams is a consultant at Monteris Medical.
Received: 22 March 2019
Accepted: 11 August 2019
17 September 2019 (online)
© 2019. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
- 1 Bondy M, Ligon BL. Epidemiology and etiology of intracranial meningiomas: a review. J Neurooncol 1996; 29 (03) 197-205
- 2 Pendleton C, Olivi A, Brem H, Quiñones-Hinojosa A. Harvey Cushing's early treatment of meningiomas: the untold story. World Neurosurg 2013; 80 (1-2): 217-221
- 3 Arora RS, Alston RD, Eden TO. et al. Are reported increases in incidence of primary CNS tumours real? An analysis of longitudinal trends in England, 1979-2003. Eur J Cancer 2010; 46 (09) 1607-1616
- 4 Gigineishvili D, Gigineishvili T, Tsiskaridze A, Shakarishvili R. Incidence rates of the primary brain tumours in Georgia--a population-based study. BMC Neurol 2014; 14: 29
- 5 Ostrom QT, Gittleman H, Liao P. et al. CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014. Neuro-oncol 2017; 19 (05) (Suppl. 05) v1-v88
- 6 Solheim O, Torsteinsen M, Johannesen TB, Jakola AS. Effects of cerebral magnetic resonance imaging in outpatients on observed incidence of intracranial tumors and patient survival: a national observational study. J Neurosurg 2014; 120 (04) 827-832
- 7 Di Maio S, Ramanathan D, Garcia-Lopez R. et al. Evolution and future of skull base surgery: the paradigm of skull base meningiomas. World Neurosurg 2012; 78 (3-4): 260-275
- 8 Buerki RA, Horbinski CM, Kruser T, Horowitz PM, James CD, Lukas RV. An overview of meningiomas. Future Oncol 2018; 14 (21) 2161-2177
- 9 Fuentes-Raspall R, Vilardell L, Perez-Bueno F. et al. Population-based incidence and survival of central nervous system (CNS) malignancies in Girona (Spain) 1994-2005. J Neurooncol 2011; 101 (01) 117-123
- 10 Bilimoria KY, Stewart AK, Winchester DP, Ko CY. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol 2008; 15 (03) 683-690
- 11 Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45 (06) 613-619
- 12 de Haan R, Aaronson N, Limburg M, Hewer RL, van Crevel H. Measuring quality of life in stroke. Stroke 1993; 24 (02) 320-327
- 13 Agarwal V, McCutcheon BA, Hughes JD. et al. Trends in management of intracranial meningiomas: analysis of 49,921 cases from modern cohort. World Neurosurg 2017; 106: 145-151
- 14 Chamoun R, Krisht KM, Couldwell WT. Incidental meningiomas. Neurosurg Focus 2011; 31 (06) E19
- 15 Jadid KD, Feychting M, Höijer J, Hylin S, Kihlström L, Mathiesen T. Long-term follow-up of incidentally discovered meningiomas. Acta Neurochir (Wien) 2015; 157 (02) 225-230 , discussion 230
- 16 Kuratsu J, Kochi M, Ushio Y. Incidence and clinical features of asymptomatic meningiomas. J Neurosurg 2000; 92 (05) 766-770
- 17 Niiro M, Yatsushiro K, Nakamura K, Kawahara Y, Kuratsu J. Natural history of elderly patients with asymptomatic meningiomas. J Neurol Neurosurg Psychiatry 2000; 68 (01) 25-28
- 18 Radhakrishnan K, Mokri B, Parisi JE, O'Fallon WM, Sunku J, Kurland LT. The trends in incidence of primary brain tumors in the population of Rochester, Minnesota. Ann Neurol 1995; 37 (01) 67-73
- 19 Ambekar S, Sharma M, Madhugiri VS, Nanda A. Trends in intracranial meningioma surgery and outcome: a Nationwide Inpatient Sample database analysis from 2001 to 2010. J Neurooncol 2013; 114 (03) 299-307
- 20 Barker II FG, Amin-Hanjani S, Butler WE, Ogilvy CS, Carter BS. In-hospital mortality and morbidity after surgical treatment of unruptured intracranial aneurysms in the United States, 1996-2000: the effect of hospital and surgeon volume. Neurosurgery 2003; 52 (05) 995-1007 , discussion 1007–1009
- 21 Cowan Jr JA, Dimick JB, Leveque JC, Thompson BG, Upchurch Jr GR, Hoff JT. The impact of provider volume on mortality after intracranial tumor resection. Neurosurgery 2003; 52 (01) 48-53 , discussion 53–54
- 22 Dolecek TA, Dressler EV, Thakkar JP, Liu M, Al-Qaisi A, Villano JL. Epidemiology of meningiomas post-Public Law 107-206: the Benign Brain Tumor Cancer Registries Amendment Act. Cancer 2015; 121 (14) 2400-2410
- 23 Cao X, Hao S, Wu Z. et al. Survival rates, prognostic factors and treatment of anaplastic meningiomas. J Clin Neurosci 2015; 22 (05) 828-833
- 24 Kumar N, Kumar R, Khosla D, Salunke PS, Gupta SK, Radotra BD. Survival and failure patterns in atypical and anaplastic meningiomas: a single-center experience of surgery and postoperative radiotherapy. J Cancer Res Ther 2015; 11 (04) 735-739
- 25 Moliterno J, Cope WP, Vartanian ED. et al. Survival in patients treated for anaplastic meningioma. J Neurosurg 2015; 123 (01) 23-30
- 26 Celtikci E, Kaymaz AM, Akgul G, Karaaslan B, Emmez OH, Borcek A. Retrospective analysis of 449 intracranial meningioma patients operated between 2007 and 2013 at a single institute. Turk Neurosurg 2018; 28 (01) 1-6
- 27 Curry WT, McDermott MW, Carter BS, Barker II FG. Craniotomy for meningioma in the United States between 1988 and 2000: decreasing rate of mortality and the effect of provider caseload. J Neurosurg 2005; 102 (06) 977-986